EBI3 anticorps (Middle Region)
Aperçu rapide pour EBI3 anticorps (Middle Region) (ABIN632221)
Antigène
Voir toutes EBI3 (IL-27b) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- EBI3 antibody was raised against the middle region of EBI3
-
Purification
- Affinity purified
-
Immunogène
- EBI3 antibody was raised using the middle region of EBI3 corresponding to a region with amino acids TAVHPWGSSSSFVPFITEHIIKPDPPEGVRLSPLAERQLQVQWEPPGSWP
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EBI3 Blocking Peptide, (ABIN5613292), is also available for use as a blocking control in assays to test for specificity of this EBI3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EBI3 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
-
Autre désignation
- EBI3
-
Sujet
- This gene was identified by its induced expression in B lymphocytes in response Epstein-Barr virus infection. It encodes a secreted glycoprotein belonging to the hematopoietin receptor family, and heterodimerizes with a 28 kDa protein to form interleukin 27 (IL-27). IL-27 regulates T cell and inflammatory responses, in part by activating the Jak/STAT pathway of CD4+ T cells.
-
Poids moléculaire
- 23 kDa (MW of target protein)
Antigène
-